Found: 39
Select item for more details and to access through your institution.
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03720-7
- By:
- Publication type:
- Article
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03725-2
- By:
- Publication type:
- Article
Treatment of stage IIIA/B non-small-cell lung cancer in era of immunotherapy: Perspective of radiotherapy.
- Published in:
- Journal of Practical Oncology, 2023, v. 38, n. 2, p. 110, doi. 10.13267/j.cnki.syzlzz.2023.019
- By:
- Publication type:
- Article
A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 307, doi. 10.3390/cancers15010307
- By:
- Publication type:
- Article
Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 180, doi. 10.3390/cancers15010180
- By:
- Publication type:
- Article
Methylation-associated silencing of miR-638 promotes endometrial carcinoma progression by targeting MEF2C.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 45, n. 6, p. 1753, doi. 10.3892/ijmm.2020.4540
- By:
- Publication type:
- Article
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
- Published in:
- Radiation Oncology, 2020, v. 15, n. 1, p. N.PAG, doi. 10.1186/s13014-020-01651-y
- By:
- Publication type:
- Article
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
LncRNA-RP11 Modulates TGF-β1-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a.
- Published in:
- Dose-Response, 2020, v. 18, n. 4, p. 1, doi. 10.1177/1559325820949071
- By:
- Publication type:
- Article
Identification of lncRNA, MicroRNA, and mRNA-Associated CeRNA Network of Radiation-Induced Lung Injury in a Mice Model.
- Published in:
- Dose-Response, 2019, v. 17, n. 4, p. N.PAG, doi. 10.1177/1559325819891012
- By:
- Publication type:
- Article
Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
- Published in:
- Disease Markers, 2018, p. 1, doi. 10.1155/2018/5736716
- By:
- Publication type:
- Article
Correction: Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 7, p. 1, doi. 10.1038/s41419-021-03928-w
- By:
- Publication type:
- Article
Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231169975
- By:
- Publication type:
- Article
A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 5, p. 1275, doi. 10.1007/s00262-021-03070-8
- By:
- Publication type:
- Article
Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4549, doi. 10.3892/ol.2017.6022
- By:
- Publication type:
- Article
Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 8, p. 2367, doi. 10.1245/s10434-019-07489-3
- By:
- Publication type:
- Article
miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
- Published in:
- Oncology Reports, 2017, v. 38, n. 3, p. 1715, doi. 10.3892/or.2017.5808
- By:
- Publication type:
- Article
Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2601, doi. 10.1002/cncr.35242
- By:
- Publication type:
- Article
Association of previously irradiated stable brain metastases with outcomes of atezolizumab‐treated non‐small cell lung cancer: A pooled analysis of individual patient data from three randomized trials.
- Published in:
- Cancer Communications, 2024, v. 44, n. 2, p. 278, doi. 10.1002/cac2.12512
- By:
- Publication type:
- Article
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial.
- Published in:
- Radiation Oncology, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13014-024-02437-2
- By:
- Publication type:
- Article
A PET/CT radiomics model for predicting distant metastasis in early-stage non–small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
- Published in:
- Radiation Oncology, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13014-024-02402-z
- By:
- Publication type:
- Article
Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01769
- By:
- Publication type:
- Article
Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6971, doi. 10.1002/cam4.5493
- By:
- Publication type:
- Article
Low‐ dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4434, doi. 10.1002/cam4.5113
- By:
- Publication type:
- Article
Is Performance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed tomography (CT) or Contrast-enhanced CT Efficient Enough to Guide the Hilar Lymph Node Staging for Patients with Esophageal Squamous Cell Carcinoma?
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.814238
- By:
- Publication type:
- Article
STING signaling activation modulates macrophage polarization via CCL2 in radiation-induced lung injury.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04446-3
- By:
- Publication type:
- Article
Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 12, p. 2510, doi. 10.7150/ijms.58954
- By:
- Publication type:
- Article
Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.
- Published in:
- Cancer Control: Journal of the Moffitt Cancer Center, 2024, p. 1, doi. 10.1177/10732748241285142
- By:
- Publication type:
- Article
Liquid-based cell suspension of supraclavicular lymph node fine-needle aspirate as an alternative specimen for NGS-based genomic profiling in advanced lung cancer.
- Published in:
- Clinical & Translational Medicine, 2020, v. 10, n. 6, p. 1, doi. 10.1002/ctm2.196
- By:
- Publication type:
- Article
Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572462
- By:
- Publication type:
- Article
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51807-7
- By:
- Publication type:
- Article
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M matters.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant nonsmall cell lung cancer with brain metastasis.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1318, doi. 10.1002/ijc.33904
- By:
- Publication type:
- Article
Identification and Integrated Analysis of circRNA and miRNA of Radiation-Induced Lung Injury in a Mouse Model.
- Published in:
- Journal of Inflammation Research, 2021, v. 14, p. 4421, doi. 10.2147/JIR.S322736
- By:
- Publication type:
- Article